Spots Global Cancer Trial Database for Evaluate Safety, Efficacy and Pharmacokinetics
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Evaluate Safety, Efficacy and Pharmacokinetics
Official Title: Double-blind Randomised Phase I/IIb Study
Study ID: NCT01084863
Conditions
Study Description
Brief Summary: The purpose of the study is to demonstrate equivalent pharmacokinetics (PK)
Detailed Description: Patients will receive CT-P6 or Herceptin.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Samsung Medical Center, Seoul, , Korea, Republic of
Contact Details
Name: Investigational Site
Affiliation: Samsung Medical Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
